
Advertisement
Advertisement
Trending on Pharmacy Times
1
FDA Approves Poherdy, First Biosimilar to Perjeta, For HER2 Breast Cancer Indications
2
Study Finds Similar Outcomes Between hMPV and RSV Hospitalizations
3
Late-Breaking Data Support Lorundrostat Treatment in Patients With CKD
4
Managing Safety and Supportive Care With Pluvicto: Insights From the PSMAddition Trial
5





